Articles
The first drug for NASH: news which is more interesting than it seems!
Zydus Cadila became the first pharmaceutical company to obtain a marketing authorization for Saroglitazar, a drug indicated for non-alcoholic steatosis of the liver (NASH), after getting the green ...